Physician profile
Lora C Denton
NPI 1669494126
$2,392.41
in general payments reported to CMS, 2019-2025
20 companies · $68.72 in 2025
The $68.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $964 · 2021: $887 · 2022: $19.07 · 2023: $67.43 · 2024: $85.63 · 2025: $68.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $750.00 | 2021 | |
| Lilly USA, LLC | $679.69 | 2020-2024 | Zepbound, Mounjaro |
| Pfizer INC. | $206.21 | 2019-2025 | |
| Biomerieux INC | $202.14 | 2020 | |
| Novartis Pharmaceuticals Corporation | $163.56 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $75.59 | 2019-2024 | Dificid, Pifeltro, Delstrigo |
| E.R. Squibb & Sons, L.L.C. | $41.07 | 2019 | |
| Novo Nordisk INC | $34.09 | 2019-2020 | |
| Mannkind Corporation | $33.73 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $28.94 | 2019-2020 | |
| Astellas Pharma US INC | $23.42 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.80 | 2020 | |
| Abbott Laboratories | $21.53 | 2023 | Freestyle Libre 3 |
| Boston Scientific Corporation | $21.17 | 2025 | Watchman Flx |
| Becton, Dickinson and Company | $19.82 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.60 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.53 | 2019 | |
| Xeris Pharmaceuticals, INC. | $14.04 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.29 | 2019 | |
| Sanofi Pasteur INC. | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.